BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2668907)

  • 1. [Kawasaki disease: recent findings in etiology, pathogenesis and therapy].
    Di Piero G; Bellisario G; Di Maggio M; Garibaldi G; Isola ML; Pauselli F; Proia R
    Pediatr Med Chir; 1989; 11(2):209-17. PubMed ID: 2668907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigenic recognition by intravenous gamma-globulin of selected bacteria isolated from throats of patients with Kawasaki syndrome.
    Lekova ES; Joffe L; Glode MP
    Pediatr Infect Dis J; 1990 Sep; 9(9):620-3. PubMed ID: 1700361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of coronary artery lesions after intravenous gamma-globulin treatment in Kawasaki disease.
    Mori M; Imagawa T; Yasui K; Kanaya A; Yokota S
    J Pediatr; 2000 Aug; 137(2):177-80. PubMed ID: 10931408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and immunologic aspects of Kawasaki disease.
    Leung DY
    Immunodefic Rev; 1989; 1(3):261-71. PubMed ID: 2698643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Kawasaki syndrome].
    Gaudelus J; Belasco C; Ovetchkine P; Camard O
    Rev Prat; 1997 Sep; 47(13):1442-6. PubMed ID: 9339024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kawasaki disease. Some recent studies on pathogenetic mechanisms.
    Tay JS
    J Singapore Paediatr Soc; 1990; 32(1-2):11-3. PubMed ID: 1701839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kawasaki disease: an overview.
    Pinna GS; Kafetzis DA; Tselkas OI; Skevaki CL
    Curr Opin Infect Dis; 2008 Jun; 21(3):263-70. PubMed ID: 18448971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous gamma globulin therapy in Kawasaki disease--trial of low dose gamma globulin.
    Okuni M; Harada K; Yamaguchi H; Yanagawa H; Sonobe T; Kawasaki T
    Prog Clin Biol Res; 1987; 250():433-9. PubMed ID: 3321083
    [No Abstract]   [Full Text] [Related]  

  • 9. [Kawasaki disease].
    Gliwińska E
    Przegl Epidemiol; 1995; 49(1-2):9-16. PubMed ID: 7545822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kawasaki disease.
    Burns JC
    Adv Pediatr; 2001; 48():157-77. PubMed ID: 11480756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum anti-Yersinia antibody in Chinese patients with Kawasaki disease.
    Chou CT; Chang JS; Ooi SE; Huo AP; Chang SJ; Chang HN; Tsai CY
    Arch Med Res; 2005; 36(1):14-8. PubMed ID: 15777989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early intravenous gamma-globulin treatment for Kawasaki disease: the nationwide surveys in Japan.
    Muta H; Ishii M; Egami K; Furui J; Sugahara Y; Akagi T; Nakamura Y; Yanagawa H; Matsuishi T
    J Pediatr; 2004 Apr; 144(4):496-9. PubMed ID: 15069399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Etiologic agent of Kawasaki disease].
    Oharaseki T; Takahashi K; Yokouchi Y; Naoe S
    Nihon Rinsho; 2008 Feb; 66(2):246-50. PubMed ID: 18260321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent mucocutaneous lymph node syndrome (Kawasaki disease): a report of three cases.
    Keren G; Passwell J; Cohen BE
    J Med; 1986; 17(5-6):365-71. PubMed ID: 3473170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kawasaki disease. Mucocutaneous lymph node syndrome or MCLS.
    Kawasaki T
    Acta Pathol Jpn; 1982; 32 Suppl 1():63-72. PubMed ID: 7187577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic impact of vascular leakage in acute Kawasaki disease.
    Terai M; Honda T; Yasukawa K; Higashi K; Hamada H; Kohno Y
    Circulation; 2003 Jul; 108(3):325-30. PubMed ID: 12835221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kawasaki disease. Kawasaki disease?
    Moss KW
    Alaska Med; 2000; 42(2):30-6. PubMed ID: 10916855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TCR V beta family repertoire and T cell activation markers in Kawasaki disease.
    Pietra BA; De Inocencio J; Giannini EH; Hirsch R
    J Immunol; 1994 Aug; 153(4):1881-8. PubMed ID: 7913945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What do we know about Kawasaki disease?
    Kucińska B; Wróblewska-Kałuzewska M
    Med Sci Monit; 2000; 6(6):1227-31. PubMed ID: 11208484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kawasaki syndrome: immunomodulatory benefit and potential toxin neutralization by intravenous immune globulin.
    Leung DY
    Clin Exp Immunol; 1996 May; 104 Suppl 1():49-54. PubMed ID: 8625544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.